Title | Journal | Journal Categories | Citations | Publication Date |
---|---|---|---|---|
A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis | Neurology |
| 2019 | |
Antibody Prevalence in Epilepsy and Encephalopathy score: Increased specificity and applicability | Epilepsia |
| 44 | 2019 |
Antibody-Mediated Encephalitis | New England Journal of Medicine |
| 2018 | |
The importance of early immunotherapy in patients with faciobrachial dystonic seizures | Brain |
| 239 | 2018 |
Human Autoantibodies against the AMPA Receptor Subunit GluA2 Induce Receptor Reorganization and Memory Dysfunction | Neuron |
| 72 | 2018 |
Title | Journal | Journal Categories | Citations | Publication Date |
---|---|---|---|---|
Management of Paraneoplastic Syndromes in the Era of Immune Checkpoint Inhibitors | Current Treatment Options in Oncology |
| 2024 | |
Performance of assessment tools in predicting neural autoantibody positivity in patients with seizures | International Immunopharmacology |
| 2024 | |
Autoimmune-associated epilepsy in an outpatient epilepsy clinic: A retrospective study | Neurology Perspectives | 2024 | ||
Utilization of APE2 and RITE2 scores in autoimmune encephalitis patients with seizures | Epilepsy & Behavior |
| 2024 | |
Paediatric antibody prevalence in seizure score to predict autoimmune aetiology in seizure disorders | Developmental Medicine & Child Neurology |
| 2024 |